Header Logo

Connection

Mehmet Altintas to Humans

Back to Details
This is a "connection" page, showing publications Mehmet Altintas has written about Humans.
Mehmet Altintas
Connection Strength
0.413
Humans
  1. Renal cell markers: lighthouses for managing renal diseases. Am J Physiol Renal Physiol. 2021 12 01; 321(6):F715-F739.
    View in: PubMed
    Score: 0.045
  2. Metabolic Changes in Peripheral Blood Mononuclear Cells Isolated From Patients With End Stage Renal Disease. Front Endocrinol (Lausanne). 2021; 12:629239.
    View in: PubMed
    Score: 0.043
  3. From Infancy to Fancy: A Glimpse into the Evolutionary Journey of Podocytes in Culture. Kidney360. 2021 02 25; 2(2):385-397.
    View in: PubMed
    Score: 0.042
  4. More expression, less function: cleaved dynamin in glomerular kidney disease. J Pathol. 2019 Apr; 247(4):413-415.
    View in: PubMed
    Score: 0.037
  5. Podocytes: Way to Go. Am J Pathol. 2019 02; 189(2):226-228.
    View in: PubMed
    Score: 0.037
  6. A High-Content Screening Technology for Quantitatively Studying Podocyte Dynamics. Adv Chronic Kidney Dis. 2017 05; 24(3):183-188.
    View in: PubMed
    Score: 0.033
  7. The D2D3 form of uPAR acts as an immunotoxin and may cause diabetes and kidney disease. Sci Transl Med. 2023 09 20; 15(714):eabq6492.
    View in: PubMed
    Score: 0.013
  8. Simultaneous stabilization of actin cytoskeleton in multiple nephron-specific cells protects the kidney from diverse injury. Nat Commun. 2022 05 03; 13(1):2422.
    View in: PubMed
    Score: 0.012
  9. Deiodinase-3 is a thyrostat to regulate podocyte homeostasis. EBioMedicine. 2021 Oct; 72:103617.
    View in: PubMed
    Score: 0.011
  10. A Novel Risk Assessment Model Using Urinary System Contrast Blush Grading to Predict Contrast-Induced Acute Kidney Injury in Low-Risk Profile Patients. Angiology. 2021 Jul; 72(6):524-532.
    View in: PubMed
    Score: 0.011
  11. Soluble Urokinase Receptor and Acute Kidney Injury. N Engl J Med. 2020 01 30; 382(5):416-426.
    View in: PubMed
    Score: 0.010
  12. Nonimmune cell-derived ICOS ligand functions as a renoprotective av?3 integrin-selective antagonist. J Clin Invest. 2019 04 01; 129(4):1713-1726.
    View in: PubMed
    Score: 0.009
  13. Single-nephron proteomes connect morphology and function in proteinuric kidney disease. Kidney Int. 2018 06; 93(6):1308-1319.
    View in: PubMed
    Score: 0.009
  14. Podocytes exhibit a specialized protein quality control employing derlin-2 in kidney disease. Am J Physiol Renal Physiol. 2018 03 01; 314(3):F471-F482.
    View in: PubMed
    Score: 0.009
  15. A tripartite complex of suPAR, APOL1 risk variants and av?3 integrin on podocytes mediates chronic kidney disease. Nat Med. 2017 Aug; 23(8):945-953.
    View in: PubMed
    Score: 0.008
  16. Apoptosis and Compensatory Proliferation Signaling Are Coupled by CrkI-Containing Microvesicles. Dev Cell. 2017 06 19; 41(6):674-684.e5.
    View in: PubMed
    Score: 0.008
  17. Soluble Urokinase Receptor and the Kidney Response in Diabetes Mellitus. J Diabetes Res. 2017; 2017:3232848.
    View in: PubMed
    Score: 0.008
  18. CD11b activation suppresses TLR-dependent inflammation and autoimmunity in systemic lupus erythematosus. J Clin Invest. 2017 Apr 03; 127(4):1271-1283.
    View in: PubMed
    Score: 0.008
  19. Soluble Urokinase Receptor and Chronic Kidney Disease. N Engl J Med. 2015 Nov 12; 373(20):1916-25.
    View in: PubMed
    Score: 0.007
  20. Role of podocyte B7-1 in diabetic nephropathy. J Am Soc Nephrol. 2014 Jul; 25(7):1415-29.
    View in: PubMed
    Score: 0.007
  21. Structure of the kidney slit diaphragm adapter protein CD2-associated protein as determined with electron microscopy. J Am Soc Nephrol. 2014 Jul; 25(7):1465-73.
    View in: PubMed
    Score: 0.007
  22. Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease. J Biol Chem. 2013 Dec 20; 288(51):36598-609.
    View in: PubMed
    Score: 0.006
  23. Small molecule agonists of integrin CD11b/CD18 do not induce global conformational changes and are significantly better than activating antibodies in reducing vascular injury. Biochim Biophys Acta. 2013 Jun; 1830(6):3696-710.
    View in: PubMed
    Score: 0.006
  24. CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survival. J Clin Invest. 2011 Oct; 121(10):3965-80.
    View in: PubMed
    Score: 0.006
  25. Prkdc participates in mitochondrial genome maintenance and prevents Adriamycin-induced nephropathy in mice. J Clin Invest. 2010 Nov; 120(11):4055-64.
    View in: PubMed
    Score: 0.005
  26. Enzymatic disease of the podocyte. Pediatr Nephrol. 2010 Jun; 25(6):1017-23.
    View in: PubMed
    Score: 0.005
  27. Modification of kidney barrier function by the urokinase receptor. Nat Med. 2008 Jan; 14(1):55-63.
    View in: PubMed
    Score: 0.004
  28. Induction of TRPC6 channel in acquired forms of proteinuric kidney disease. J Am Soc Nephrol. 2007 Jan; 18(1):29-36.
    View in: PubMed
    Score: 0.004
  29. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet. 2005 Jul; 37(7):739-44.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.